Luciferase In Vivo

E. coli in vivo Biotinylation Kit

27461 10 x 1L
EUR 530
Description: The E. coli in vivo biotinylation kit comes in a convenient, easy-to-use format and contains all the components necessary to label biotin-acceptor peptides with biotin in E. coli. Strain BL21, a chemically competent E. coli B strain. The cells include an IPTG-inducible plasmid containing the BirA gene and the resistance gene for streptomycin or spectinomycin. Just transform the competent cells with a vector expressing your protein of interest with an AviTag™ sequence (example: pAN or pAC vectors). After transformation, BirA expression is induced and biotin is added to the culture. The BirA efficiently catalyzes the specific attachment of biotin to the AviTag.

Human IgG antibody Laboratories manufactures the luciferase in vivo reagents distributed by Genprice. The Luciferase In Vivo reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Luciferase products are available in stock. Specificity: Luciferase Category: In Group: Vivo

RFP expression Adenovirus, in vivo ready

1x1011 IFU/ml x 50ul
EUR 852
Description: pre-made RFP expression adenovirus, provided in PBS solution.

CFP expression Adenovirus, in vivo ready

1x1011 IFU/ml x 50ul
EUR 852
Description: pre-made CFP expression adenovirus, provided in PBS solution.

Luciferase / GFP Adenovirus, in vivo ready

1x1011 IFU/ml x 50ul
EUR 852
Description: pre-made Luciferase / GFP expression adenovirus, provided in PBS solution.

Luciferase / RFP Adenovirus, in vivo ready

1x1011 IFU/ml x 50ul
EUR 852
Description: pre-made Luciferase / RFP expression adenovirus, provided in PBS solution.

CRISPR / hCas9 Adenovirus, in vivo ready

1x1011 IFU/ml x 50ul
EUR 852
Description: pre-made adenovirus expresses the neclear penetrated, human codon optimized wild-type Cas9 endonuclease, provided in PBS solution.

GFP expression Adenovirus, in vivo ready

1x1011 IFU/ml x 50ul
EUR 852
Description: pre-made GFP expression adenovirus, provided in PBS solution.

YFP expression Adenovirus, in vivo ready

1x1011 IFU/ml x 50ul
EUR 852
Description: pre-made YFP expression adenovirus, provided in PBS solution.

Vivo information

Luciferase

enz-553 5µg
EUR 60
Description: Recombinant Firefly Luciferin 4-Monooxygenase

Luciferase

TP1344-10mg 10mg Ask for price
Description: Luciferase

Luciferase

TP1344-1g 1g Ask for price
Description: Luciferase

Luciferase

TP1344-1mg 1mg Ask for price
Description: Luciferase

Luciferase

TP1344-50mg 50mg Ask for price
Description: Luciferase

Luciferase

TP1344-5mg 5mg Ask for price
Description: Luciferase

Luciferase

1107NF-V10274 0.5/ml
EUR 199

CMV-Luciferase, in vivo read  (No Marker)

LVP911a-PBS 5x107 IFU/ml x 200ul
EUR 852
Description: Pre-made lentivirus express firefly luciferase under CMV promoter (do not containing any antibiotic selection marker), concentrated and provided in PBS solution

AAV1 Luciferase

78452 50 µl x 2
EUR 545
Description: Adeno-Associated Virus Serotype 1 (AAV1) exhibits high homology with other AAV serotypes. AAV1 efficiently transduces muscle tissue, as determined by a region of the capsid protein VP1 (amino acids 350 to 430) which functions as a major determinant of tissue tropism._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase under the control of a CMV promoter.

AAV2 Luciferase

78453 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 2 (AAV2) is the best characterized AAV serotype. Nearly all recombinant AAV serotypes utilize the AAV2 inverted terminal repeats (ITRs). AAV2 requires the expression of Heparan Sulfate Proteoglycan (HSPG) on the surface of host for cells for binding and internalization. Of nearly all the discovered AAV serotypes, AAV2 has the best transduction efficiency in cell culture and is the best tool for in vitro studies._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase under the control of a CMV promoter.

AAV3 Luciferase

78454 50 µl x 2
EUR 545
Description: Adeno-Associated Virus Serotype 3 (AAV3) shares 82% sequence homology with AAV2, and like AAV2, requires the Heparan Sulfate Proteoglycan (HSPG) receptor for cell attachment. AAV3 vectors transduce human liver cancer cells extremely efficiently because AAV3 utilizes the human Hepatocyte Growth Factor Receptor (hHGFR) as a co-receptor for viral entry, which is highly expressed in these cells. Both the extracellular and intracellular kinase domains of hHGFR are required for AAV3-mediated transgene expression._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

AAV5 Luciferase

78456 50 µl x 2
EUR 545
Description: Adeno-Associated Virus Serotype 5 (AAV5) differs from other parvovirus serotypes according to serological and DNA hybridization data, and AAV5 also uses different inverted terminal repeats (ITRs) compared to other AAV serotypes. AAV5 is the most efficient vector for transducing sensory neurons and is effective at mediating gene transfer into human and murine airway epithelia. In addition, AAV5 vectors show a higher tropism for both mouse and human dendritic cells than AAV1, AAV2, AAV7, or AAV8._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

AAV6 Luciferase

78457 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 6 (AAV6) appears to be related to AAV1 by sequence analysis and shows the best transduction efficiency in pancreatic beta-cells compared to other AAV serotypes. AAV6 vectors are also particularly effective in the transduction of human prostate, breast, and liver cancer cells._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

AAV8 Luciferase

78458 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 8 (AAV8) was isolated from rhesus monkey tissue, and the AAV8 rep and cap nucleotide sequences have 88% homology with AAV7 and 82% with AAV2. AAV8 exhibits greater transduction efficiency in the liver than other AAV serotypes. AAV8 and 9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

AAV9 Luciferase

78459 50 µl x 2
EUR 545
Description: Adeno-Associated Virus serotype 9 (AAV9) is one of the most promising serotypes for gene therapy applications. AAV9 transduces a wide range of tissue types, including cardiac and skeletal muscle, liver, pancreas, and eye tissue. AAV8 and AAV9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy. AAV9 has significantly lower seroprevalence in the human population than other AAV serotypes, making AAV9 a desirable candidate for therapeutic applications.         _x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase gene under the control of a CMV promoter. AAV transduction efficiency can easily be verified by measurement of luciferase activity.

EF1a-Luciferase, in vivo read  (No Marker)

LVP911b-PBS 5x107 IFU/ml x 200ul
EUR 852
Description: Pre-made lentivirus express firefly luciferase under EF1a promoter (do not containing any antibiotic selection marker), concentrated and provided in PBS solution

CMV-Luciferase (firefly), (Neo), in vivo ready

LVP283-PBS 5 x107 IFU/ml x 200ul
EUR 852
Description: Pre-made lucifierase (firefly) lentiviral particles. Luciferase was expressed under a tetrcycline inducible suCMV promoter. A Neomycin marker was expressed under RSV promoter. Paticles was concentrated and buffer changed into PBS.